Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychopharmacology | 10 | 2022 | 143 | 4.240 |
Why?
|
| Antipsychotic Agents | 19 | 2022 | 3058 | 2.210 |
Why?
|
| Algorithms | 19 | 2020 | 13853 | 1.230 |
Why?
|
| Bipolar Disorder | 9 | 2020 | 5024 | 0.730 |
Why?
|
| Antidepressive Agents | 7 | 2020 | 2838 | 0.700 |
Why?
|
| Prazosin | 3 | 2022 | 96 | 0.670 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2022 | 4248 | 0.650 |
Why?
|
| Anti-Anxiety Agents | 3 | 2016 | 390 | 0.610 |
Why?
|
| Electroconvulsive Therapy | 5 | 2020 | 472 | 0.570 |
Why?
|
| Psychotic Disorders | 6 | 2022 | 3040 | 0.560 |
Why?
|
| Drug Synergism | 2 | 2019 | 1791 | 0.540 |
Why?
|
| Obsessive-Compulsive Disorder | 3 | 2019 | 1442 | 0.510 |
Why?
|
| Antidepressive Agents, Second-Generation | 3 | 2013 | 503 | 0.500 |
Why?
|
| Haloperidol | 5 | 2022 | 397 | 0.500 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 997 | 0.460 |
Why?
|
| Clinical Protocols | 3 | 2014 | 1459 | 0.450 |
Why?
|
| Risperidone | 4 | 2020 | 383 | 0.450 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 647 | 0.420 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2013 | 105 | 0.420 |
Why?
|
| Benzodiazepines | 5 | 2022 | 1101 | 0.420 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2749 | 0.360 |
Why?
|
| Depressive Disorder | 4 | 2019 | 3748 | 0.360 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 174 | 0.330 |
Why?
|
| Drug Therapy, Combination | 6 | 2022 | 6483 | 0.320 |
Why?
|
| Dementia | 2 | 2020 | 2501 | 0.310 |
Why?
|
| Schizophrenia | 7 | 2013 | 6874 | 0.310 |
Why?
|
| Anxiety Disorders | 2 | 2016 | 2684 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 7276 | 0.270 |
Why?
|
| Psychomotor Agitation | 2 | 2022 | 288 | 0.250 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2017 | 874 | 0.230 |
Why?
|
| Adrenergic Antagonists | 1 | 2022 | 24 | 0.220 |
Why?
|
| Promethazine | 1 | 2022 | 29 | 0.210 |
Why?
|
| Chest Pain | 1 | 2009 | 1113 | 0.200 |
Why?
|
| Dreams | 1 | 2022 | 147 | 0.200 |
Why?
|
| Lorazepam | 1 | 2022 | 145 | 0.200 |
Why?
|
| Fluvoxamine | 1 | 2020 | 74 | 0.180 |
Why?
|
| Clomipramine | 1 | 2019 | 54 | 0.180 |
Why?
|
| Pirenzepine | 1 | 1999 | 115 | 0.170 |
Why?
|
| Antimanic Agents | 2 | 2015 | 522 | 0.170 |
Why?
|
| Irritable Mood | 1 | 2020 | 183 | 0.170 |
Why?
|
| Citalopram | 1 | 2020 | 404 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2008 | 1952 | 0.150 |
Why?
|
| Social Isolation | 1 | 2020 | 363 | 0.150 |
Why?
|
| Psychotropic Drugs | 2 | 2020 | 893 | 0.150 |
Why?
|
| Telecommunications | 1 | 2017 | 80 | 0.150 |
Why?
|
| Telemedicine | 3 | 2020 | 2853 | 0.140 |
Why?
|
| Naltrexone | 1 | 1998 | 307 | 0.140 |
Why?
|
| Depressive Disorder, Major | 2 | 2018 | 4628 | 0.140 |
Why?
|
| Humans | 41 | 2022 | 742088 | 0.140 |
Why?
|
| Affective Symptoms | 1 | 2018 | 407 | 0.130 |
Why?
|
| Comorbidity | 3 | 2020 | 10372 | 0.130 |
Why?
|
| Patient Care Team | 2 | 2017 | 2527 | 0.130 |
Why?
|
| Evidence-Based Medicine | 3 | 2012 | 3611 | 0.130 |
Why?
|
| Narcotic Antagonists | 1 | 1998 | 562 | 0.120 |
Why?
|
| Videoconferencing | 1 | 2016 | 195 | 0.120 |
Why?
|
| Sulpiride | 1 | 2013 | 17 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 865 | 0.110 |
Why?
|
| Mesoridazine | 1 | 1991 | 2 | 0.100 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2011 | 25 | 0.100 |
Why?
|
| Curriculum | 1 | 2005 | 3589 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 1953 | 0.100 |
Why?
|
| Mianserin | 1 | 2011 | 52 | 0.100 |
Why?
|
| Triglycerides | 1 | 1999 | 2450 | 0.100 |
Why?
|
| Trazodone | 1 | 2011 | 66 | 0.100 |
Why?
|
| Piperazines | 2 | 2013 | 2488 | 0.100 |
Why?
|
| Dibenzazepines | 1 | 1990 | 26 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8621 | 0.090 |
Why?
|
| Dibenzothiazepines | 1 | 2010 | 104 | 0.090 |
Why?
|
| Quinolones | 1 | 2013 | 366 | 0.090 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2011 | 434 | 0.090 |
Why?
|
| Weight Gain | 1 | 1999 | 2282 | 0.090 |
Why?
|
| Lithium Carbonate | 1 | 2010 | 184 | 0.090 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1988 | 71 | 0.080 |
Why?
|
| Alcoholism | 1 | 1998 | 1904 | 0.080 |
Why?
|
| Phobic Disorders | 1 | 2010 | 439 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 2407 | 0.080 |
Why?
|
| Triazines | 1 | 2010 | 316 | 0.080 |
Why?
|
| Adult | 9 | 2020 | 213712 | 0.070 |
Why?
|
| Clozapine | 1 | 1990 | 498 | 0.070 |
Why?
|
| Fluoxetine | 1 | 2010 | 749 | 0.070 |
Why?
|
| Triazoles | 1 | 2011 | 907 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2005 | 5774 | 0.070 |
Why?
|
| Thiazoles | 1 | 2013 | 1484 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2003 | 10943 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2010 | 2615 | 0.060 |
Why?
|
| Community Mental Health Services | 1 | 2007 | 386 | 0.060 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 4929 | 0.060 |
Why?
|
| Cohort Effect | 1 | 2003 | 39 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 3649 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5304 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2011 | 1914 | 0.050 |
Why?
|
| International Cooperation | 2 | 2018 | 1421 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
| Female | 10 | 2020 | 379592 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 1503 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 506 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2017 | 2485 | 0.040 |
Why?
|
| Male | 10 | 2020 | 349538 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 1 | 2018 | 332 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 1993 | 6030 | 0.040 |
Why?
|
| Hypertriglyceridemia | 1 | 1999 | 293 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 1402 | 0.030 |
Why?
|
| Psychiatry | 2 | 2005 | 1695 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 162944 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2017 | 559 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 854 | 0.030 |
Why?
|
| China | 1 | 2018 | 2246 | 0.030 |
Why?
|
| United States | 5 | 2020 | 69693 | 0.030 |
Why?
|
| Research Design | 2 | 2003 | 5979 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 3266 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12958 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1246 | 0.020 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1989 | 164 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2003 | 9144 | 0.020 |
Why?
|
| Personality Disorders | 1 | 1993 | 708 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2017 | 2680 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2005 | 6587 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4214 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 1831 | 0.020 |
Why?
|
| Texas | 1 | 2006 | 392 | 0.020 |
Why?
|
| Internet | 1 | 1998 | 3062 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3391 | 0.020 |
Why?
|
| Middle Aged | 5 | 2018 | 213127 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2010 | 62966 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 2006 | 437 | 0.010 |
Why?
|
| Pregnancy | 2 | 2020 | 29087 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1990 | 1548 | 0.010 |
Why?
|
| Quality of Health Care | 2 | 2017 | 4369 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 1990 | 1677 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15194 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 168561 | 0.010 |
Why?
|
| Veterans | 1 | 2014 | 2513 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 2006 | 605 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4440 | 0.010 |
Why?
|
| Hospitalization | 1 | 1999 | 10232 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 40054 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 57683 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2008 | 2055 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15530 | 0.010 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2006 | 1431 | 0.010 |
Why?
|
| Disease Management | 1 | 2006 | 2450 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1990 | 7901 | 0.010 |
Why?
|
| Brain | 1 | 1990 | 26343 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1990 | 77098 | 0.000 |
Why?
|
| Social Values | 1 | 1981 | 224 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 1981 | 3215 | 0.000 |
Why?
|
| Clinical Competence | 1 | 1981 | 4681 | 0.000 |
Why?
|
Concepts
(149)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_